Andrea Matthews - Apr 17, 2023 Form 4 Insider Report for Astria Therapeutics, Inc. (ATXS)

Role
Chief Business Officer
Signature
/s/ Ben Harshbarger, as attorney-in-fact for Andrea Matthews
Stock symbol
ATXS
Transactions as of
Apr 17, 2023
Transactions value $
$0
Form type
4
Date filed
4/19/2023, 08:10 AM
Next filing
Jun 6, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ATXS Stock Option (Right to Buy) Award $0 +20K $0.00 20K Apr 17, 2023 Common Stock 20K $10.82 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option was granted on April 17, 2023 and is subject to vesting over a four-year period, with 25% of the 20,000 shares underlying the option upon grant vesting on the first anniversary of April 17, 2023 and the remainder vesting over the ensuing three years in equal monthly installments.